methadone:
  - "H0020"
  - "J1230"
  - "G2067"
  - "G2078"
  - "S0109"

buprenorphine:
  - "J0570" # Buprenorphine implant, 74.2 mg
  - "J0572" # Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
  - "J0573" # Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
  - "J0574" # Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
  - "J0575" # Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
  - "Q9991" # Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
  - "Q9992" # Injection, buprenorphine extended-release (sublocade), greater than 100 mg
  - "G2068" # Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
  - "G2069" # Medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
  - "G2070" # Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
  - "G2071" # Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
  - "G2072" # Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
  - "G2079" # Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

naltrexone:
  - "J2315"
  - "G2073"
